Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Calimmune commences phase I/II trial of gene medicine for HIV

July 10, 2013

Gilead Sciences presents further clinical data on Stribild

July 9, 2013

Coadministration of long-acting GSK-744 and rilpivirine found feasible

July 8, 2013

Results from phase III trials of dolutegravir presented

July 5, 2013

In vitro and in vivo anti-HIV activity of a novel HIV-1 splicing inhibitor

July 4, 2013

Janssen presents bioequivalence results for darunavir/cobicistat fixed-drug combination

July 3, 2013

Bionor Pharma obtains GLOBVAC grant to advance research on Vacc-HIV

June 25, 2013

AiCuris patents novel reverse transcriptase inhibitors for HIV infection

June 25, 2013

Bionor Pharma completes first part of phase II study combining Vacc-4x with Revlimid

June 14, 2013

Amrita Therapeutics discloses novel antiviral proteins

June 14, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 4, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...